Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis

John P. Fitzgerald, Barbara Ercole, Dipen J. Parekh

Research output: Contribution to journalArticle

1 Scopus citations


The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.

Original languageEnglish (US)
Pages (from-to)98-101
Number of pages4
JournalIndian Journal of Urology
Issue number1
Publication statusPublished - Jan 1 2010



  • Cancer
  • Testis

ASJC Scopus subject areas

  • Urology

Cite this